Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Peptide hormones are hormones made of short chains of amino acids that travel through the blood and signal target cells by binding to receptors on the cell surface. Familiar examples include insulin, growth hormone, oxytocin, and GLP-1. Because they are water-soluble, they act through second-messenger pathways rather than entering cells directly [1].
What are peptide hormones?
Peptide hormones are chemical messengers built from amino acids, the same building blocks used to make proteins. They are made by endocrine cells, released into the blood, and read by target tissues that carry the right receptor [1].
A peptide hormone can be very small, like oxytocin, or much larger, like growth hormone. The key idea is that its message is carried by an amino acid chain rather than by a fat-based steroid structure [1].
How peptide hormones differ from steroid hormones
Peptide hormones are water-soluble, so they usually cannot pass through the oily cell membrane. Steroid hormones are lipid-soluble, so they can enter cells and bind receptors inside the cell or nucleus [1,2].
| Feature | Peptide hormones | Steroid hormones |
|---|---|---|
| Chemical structure | Amino acid chains | Cholesterol-derived lipids |
| Solubility | Water-soluble | Fat-soluble |
| Main receptor location | Cell surface | Inside the cell or nucleus |
| Common signal pathway | Second messengers such as cAMP or Ca2+ | Direct effects on gene transcription |
| Examples | Insulin, GLP-1, oxytocin, growth hormone | Cortisol, estrogen, testosterone, aldosterone |
Where peptide hormones are made in the body
Peptide hormones are made in many organs, including the pituitary gland, pancreas, gut, thyroid, parathyroid glands, and hypothalamus. For example, pancreatic beta cells make insulin, intestinal L cells make GLP-1, and the posterior pituitary releases oxytocin and vasopressin made in the hypothalamus [1,3,4].
How are peptide hormones made and released?
Peptide hormones are usually made first as larger starter proteins, then cut and processed into active hormones. This processing helps cells package the hormone safely and release it only when a signal arrives [1,2].
From preprohormone to active hormone
Many peptide hormones begin as a preprohormone. The cell removes a signal peptide to form a prohormone, then enzymes cut the prohormone into the active hormone before secretion [1,2].
Insulin is a classic example. It is made as preproinsulin, processed to proinsulin, then cleaved into insulin and C-peptide before release from pancreatic beta cells [3].
How they are stored and secreted
Unlike many steroid hormones, peptide hormones are often stored in secretory granules. When the cell receives the right trigger, such as rising glucose for insulin, the granules fuse with the cell membrane and release hormone into the blood [2,3].
How do peptide hormones signal cells?
Peptide hormones usually signal by binding to receptors on the outside of target cells. That binding turns on inside-the-cell pathways, often using second messengers such as cyclic AMP, calcium ions, or phosphoinositide signals [2].
Receptor binding and second messengers
Second messengers are small signals inside a cell. For example, glucagon and GLP-1 receptors can activate cAMP pathways, while oxytocin and vasopressin receptors can signal through calcium-linked pathways in some tissues [2,4,5].
Why they cannot cross the cell membrane
Cell membranes contain a fatty layer. Water-soluble peptide hormones do not pass through that layer easily, so they rely on cell-surface receptors to deliver the message [1,2].
What are the four main peptide hormones people ask about?
There is no official list of only four peptide hormones, because the human body makes many. In search and patient questions, the four that come up most often are insulin, growth hormone, oxytocin, and GLP-1 [1,3,4,8].
- Insulin: helps move glucose from blood into cells and is essential in diabetes care when the body does not make or use enough insulin [3].
- Growth hormone, also called somatotropin: supports growth in children and has metabolic effects in adults; prescription growth hormone has FDA-approved uses but also safety limits [6].
- Oxytocin: involved in labor, uterine contraction, milk let-down, and social-bonding biology; prescription oxytocin is used in obstetric care under clinical monitoring [4].
- GLP-1, or glucagon-like peptide-1: an incretin hormone involved in insulin secretion, glucagon regulation, appetite signaling, and gastric emptying; GLP-1 receptor agonist medicines are used for type 2 diabetes and chronic weight management when label criteria are met [8,12].
Benefits should not be viewed alone. Insulin can cause hypoglycemia and weight gain, growth hormone can cause swelling or joint pain, oxytocin can overstimulate uterine contractions, and GLP-1 medicines commonly cause nausea, vomiting, diarrhea, constipation, or abdominal pain [6,8,13].
What are examples of peptide hormones in the human body?
Peptide hormones are found across the endocrine system. A practical list includes pituitary hormones, pancreatic hormones, gut and appetite hormones, and calcium-regulating hormones [1].
Pituitary hormones
The pituitary gland releases several peptide or protein hormones, including growth hormone, ACTH, TSH, LH, FSH, and prolactin. These hormones help coordinate adrenal, thyroid, reproductive, growth, and lactation signals [1,6].
Pancreatic hormones
The pancreas makes insulin, glucagon, somatostatin, pancreatic polypeptide, and amylin. Insulin lowers blood glucose, while glucagon helps raise blood glucose during fasting; diabetes care often focuses on these pathways [3,13].
Gut and appetite hormones
Gut and appetite signals include GLP-1, GIP, ghrelin, cholecystokinin, peptide YY, and leptin. GLP-1 and GIP are incretins, meaning they help the body release insulin after food intake [12].
Leptin is made mainly by fat tissue and signals energy stores to the brain. Ghrelin is made mainly by the stomach and rises before meals in many settings [14,15].
Other key peptide hormones
Other important peptide hormones include oxytocin, vasopressin or antidiuretic hormone, parathyroid hormone, and calcitonin. Vasopressin helps regulate water balance, while parathyroid hormone and calcitonin help regulate calcium physiology [1,4,5].
| Hormone | Main source | Main role | Medicine connection |
|---|---|---|---|
| Insulin | Pancreatic beta cells | Blood glucose control | Prescription insulin is used for diabetes care [13] |
| Glucagon | Pancreatic alpha cells | Raises blood glucose during fasting | Prescription glucagon is used for severe hypoglycemia [13] |
| Growth hormone | Anterior pituitary | Growth and metabolism | Prescription somatropin has FDA-approved uses with monitoring [6] |
| Oxytocin | Hypothalamus; released by posterior pituitary | Uterine contraction and milk let-down | Prescription oxytocin is used in obstetric care [4] |
| GLP-1 | Intestinal L cells | Incretin and appetite signaling | GLP-1 receptor agonists are used for diabetes and weight management when indicated [8,12] |
| GIP | Intestinal K cells | Incretin signaling | Tirzepatide acts at GIP and GLP-1 receptors [10,11] |
How are peptide hormones used as medicines?
Peptide hormone medicines are used when a hormone pathway needs to be replaced, activated, or adjusted. They can be very helpful in the right setting, but they also require diagnosis, contraindication review, side-effect counseling, and monitoring [13].
Insulin and diabetes
Insulin is an FDA-approved peptide hormone therapy for diabetes. The American Diabetes Association recommends insulin as required treatment for type 1 diabetes and as one option for type 2 diabetes when clinically indicated [13].
The main safety concern is low blood sugar, called hypoglycemia. Other possible issues include injection-site reactions, weight gain, and the need for careful dose adjustment by a clinician [13].
GLP-1 receptor agonists for weight and diabetes
Semaglutide, sold as Ozempic for type 2 diabetes and Wegovy for chronic weight management, is a GLP-1 receptor agonist; it is also available as compounded semaglutide through some licensed 503A pharmacies when legally permitted and prescribed. The FDA-approved Wegovy label lists a starting dose of 0.25 mg once weekly for 4 weeks with titration toward a maintenance dose of 2.4 mg once weekly [8].
Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, is a GIP and GLP-1 receptor agonist; it is also available as compounded tirzepatide through some licensed 503A pharmacies when legally permitted and prescribed. The FDA-approved Zepbound label lists a starting dose of 2.5 mg once weekly for 4 weeks, followed by stepwise dose increases if appropriate [10].
In the STEP 1 trial, semaglutide 2.4 mg once weekly was associated with greater mean weight loss than placebo in adults with overweight or obesity; individual results vary [16]. In the SURMOUNT-1 trial, tirzepatide 5 mg, 10 mg, or 15 mg once weekly was associated with greater mean weight reduction than placebo; individual results vary [17].
These benefits must be weighed against safety risks. GLP-1 and GIP/GLP-1 medicines commonly cause nausea, vomiting, diarrhea, constipation, and abdominal pain, and labels include warnings such as pancreatitis, gallbladder disease, kidney injury from dehydration, and a boxed warning about thyroid C-cell tumors based on rodent data [8,10].
Growth hormone, oxytocin, and other therapeutic peptides
Prescription somatropin, a form of human growth hormone, is FDA-approved for specific pediatric and adult indications listed in product labeling. It is not a general wellness drug, and safety concerns include fluid retention, joint pain, glucose changes, and contraindications such as active malignancy or acute critical illness in some settings [6].
Oxytocin is an FDA-approved obstetric medication used under medical supervision for specific labor and postpartum indications. It can cause uterine overstimulation, fetal heart rate changes, water intoxication in rare cases, and other risks, so it is not used casually [4].
What are the potential side effects of peptide hormone therapy?
Peptide hormone therapy side effects depend on the hormone, dose, medical history, and other medicines. Because peptide medicines act on real hormone pathways, they can cause meaningful benefits and meaningful risks [13].
- Insulin: low blood sugar, weight gain, injection-site reactions, and dosing errors that can be serious [13].
- GLP-1 receptor agonists: nausea, vomiting, diarrhea, constipation, abdominal pain, possible gallbladder problems, pancreatitis warnings, kidney injury risk from dehydration, and label-specific contraindications [8,9,10,11].
- Growth hormone: swelling, joint pain, carpal tunnel symptoms, glucose changes, and contraindications in some cancer or critical illness settings [6].
- Oxytocin: uterine overstimulation, fetal heart rate changes, low sodium in rare cases, and risks tied to labor management [4].
- Vasopressin-related therapy: water balance and sodium changes can occur, depending on the medicine and indication [5].
A clinician should review pregnancy status, personal or family endocrine cancer history, pancreatitis history, gallbladder disease, kidney disease, diabetes medicines, and current prescriptions before starting peptide-based treatment [8,10,13].
How do you get access to peptide hormone treatments?
Peptide hormone treatments require a clinical evaluation because the right choice depends on diagnosis, labs, medical history, contraindications, and goals. Some medicines are FDA-approved products, while some compounded options are prepared by licensed 503A pharmacies for an individual prescription when allowed by law [18].
A typical safe path is to meet with a licensed clinician, review your health history, confirm whether the therapy matches an approved or legally permitted use, and use a licensed pharmacy. Chia is one telehealth option that offers clinician-reviewed access to compounded GLP-1s and select peptide therapies when appropriate, with prescriptions sent only when a clinician determines they are suitable.
3-min quiz
Considering a prescription peptide therapy?
A licensed clinician can help you understand whether a peptide-based treatment fits your health history, goals, and safety profile.
Frequently asked questions
They are related but not always the same size. Peptide hormones are amino acid chains. Some are small peptides, while others are larger protein hormones, such as growth hormone [1].
Yes. GLP-1 receptor agonists such as semaglutide are peptide-based medicines that mimic or activate GLP-1 signaling. Tirzepatide is a peptide-based medicine that acts at GIP and GLP-1 receptors [8,10,12].
There is no official set of only four. The four people often ask about are insulin, growth hormone, oxytocin, and GLP-1, but the body has many more peptide hormones [1].
Most peptide hormones do not enter cells easily because they are water-soluble. They usually bind receptors on the cell surface and signal through second messengers such as cAMP or calcium [1,2].
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved drugs. They may be prepared by licensed pharmacies for an individual patient under a valid prescription when federal and state rules allow [18].
Yes. Side effects depend on the hormone. Examples include hypoglycemia with insulin, stomach symptoms with GLP-1 medicines, swelling or joint pain with growth hormone, and labor-related risks with oxytocin [4,6,8,13].
AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP (mcp.chia.health). A prescription still requires review by a licensed clinician and is not guaranteed.
3-min quiz
Learn about compounded options
If you are exploring peptide-based treatment, start with a clinical review and clear safety screening rather than guessing on your own.
References
- 1.Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, editors. Williams Textbook of Endocrinology: peptide and protein hormones overview, Elsevier, 2020.
- 2.Alberts B, Johnson A, Lewis J, Morgan D, Raff M, Roberts K, Walter P. Molecular Biology of the Cell: cell signaling and second messengers, Garland Science, 2015.
- 3.Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes, Current Diabetes Reviews, 2013.
- 4.U.S. Food and Drug Administration. Pitocin (oxytocin injection) prescribing information, 2024.
- 5.Bankir L, Bichet DG, Morgenthaler NG. Vasopressin: physiology, assessment and osmosensation, Journal of Internal Medicine, 2017.
- 6.U.S. Food and Drug Administration. Genotropin (somatropin) prescribing information, 2023.
- 7.Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP, Gastroenterology, 2007.
- 8.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information, 2024.
- 9.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information, 2024.
- 10.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information, 2024.
- 11.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information, 2024.
- 12.Nauck MA, Meier JJ. Incretin hormones: their role in health and disease, Diabetes, Obesity and Metabolism, 2018.
- 13.American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes—2024, Diabetes Care, 2024.
- 14.Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue, Nature, 1994.
- 15.Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, 1999.
- 16.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine, 2021.
- 17.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity, New England Journal of Medicine, 2022.
- 18.U.S. Food and Drug Administration. Compounding and the FDA: questions and answers, 2024.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



